Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface

Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantificati...

Full description

Bibliographic Details
Main Authors: Alexander Rodríguez, Francisco Burgos-Flórez, José D. Posada, Eliana Cervera, Valtencir Zucolotto, Homero Sanjuán, Marco Sanjuán, Pedro J. Villalba
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/21/6/1929
id doaj-2d6cb52377924e409e6abd7df726cc51
record_format Article
spelling doaj-2d6cb52377924e409e6abd7df726cc512021-03-11T00:00:16ZengMDPI AGSensors1424-82202021-03-01211929192910.3390/s21061929Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified SurfaceAlexander Rodríguez0Francisco Burgos-Flórez1José D. Posada2Eliana Cervera3Valtencir Zucolotto4Homero Sanjuán5Marco Sanjuán6Pedro J. Villalba7Biotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaSchool of Medicine, Stanford University, Redwood City, CA 94063, USABiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaGnano—Nanomedicine and Nanotoxicology Group, São Carlos Institute of Physics, University of São Paulo, São Carlos 13566-590, São Paulo, BrazilBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaRational Use of Energy and Preservation of the Environment Group (UREMA), Universidad del Norte, Barranquilla 081007, ColombiaBiotechnology Research Group, Universidad del Norte, Barranquilla 081007, ColombiaNeuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise. A zero-length cross-linking approach on a cysteamine self-assembled monolayer (SAM) was performed to immobilize anti-S100B monoclonal antibodies onto both planar (AuEs) and interdigitated (AuIDEs) gold electrodes via carbonyl-bond. Surface characterization was performed by atomic force microscopy (AFM) and specular-reflectance FTIR for each functionalization step. Biosensor response was studied using the change in charge-transfer resistance (Rct) from electrochemical impedance spectroscopy (EIS) in potassium ferrocyanide, with [S100B] ranging 10–1000 pg/mL. A single-frequency analysis for capacitances was also performed in AuIDEs. Full factorial designs were applied to assess biosensor sensitivity, specificity, and limit-of-detection (LOD). Higher Rct values were found with increased S100B concentration in both platforms. LODs were 18 pg/mL(AuES) and 6 pg/mL(AuIDEs). AuIDEs provide a simpler manufacturing protocol, with reduced fabrication time and possibly costs, simpler electrochemical response analysis, and could be used for single-frequency analysis for monitoring capacitance changes related to S100B levels.https://www.mdpi.com/1424-8220/21/6/1929biosensorgold electrodeselectrochemical impedance spectroscopybrain injuriesS-100Bbiomarker
collection DOAJ
language English
format Article
sources DOAJ
author Alexander Rodríguez
Francisco Burgos-Flórez
José D. Posada
Eliana Cervera
Valtencir Zucolotto
Homero Sanjuán
Marco Sanjuán
Pedro J. Villalba
spellingShingle Alexander Rodríguez
Francisco Burgos-Flórez
José D. Posada
Eliana Cervera
Valtencir Zucolotto
Homero Sanjuán
Marco Sanjuán
Pedro J. Villalba
Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
Sensors
biosensor
gold electrodes
electrochemical impedance spectroscopy
brain injuries
S-100B
biomarker
author_facet Alexander Rodríguez
Francisco Burgos-Flórez
José D. Posada
Eliana Cervera
Valtencir Zucolotto
Homero Sanjuán
Marco Sanjuán
Pedro J. Villalba
author_sort Alexander Rodríguez
title Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
title_short Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
title_full Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
title_fullStr Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
title_full_unstemmed Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface
title_sort electrochemical immunosensor for the quantification of s100b at clinically relevant levels using a cysteamine modified surface
publisher MDPI AG
series Sensors
issn 1424-8220
publishDate 2021-03-01
description Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise. A zero-length cross-linking approach on a cysteamine self-assembled monolayer (SAM) was performed to immobilize anti-S100B monoclonal antibodies onto both planar (AuEs) and interdigitated (AuIDEs) gold electrodes via carbonyl-bond. Surface characterization was performed by atomic force microscopy (AFM) and specular-reflectance FTIR for each functionalization step. Biosensor response was studied using the change in charge-transfer resistance (Rct) from electrochemical impedance spectroscopy (EIS) in potassium ferrocyanide, with [S100B] ranging 10–1000 pg/mL. A single-frequency analysis for capacitances was also performed in AuIDEs. Full factorial designs were applied to assess biosensor sensitivity, specificity, and limit-of-detection (LOD). Higher Rct values were found with increased S100B concentration in both platforms. LODs were 18 pg/mL(AuES) and 6 pg/mL(AuIDEs). AuIDEs provide a simpler manufacturing protocol, with reduced fabrication time and possibly costs, simpler electrochemical response analysis, and could be used for single-frequency analysis for monitoring capacitance changes related to S100B levels.
topic biosensor
gold electrodes
electrochemical impedance spectroscopy
brain injuries
S-100B
biomarker
url https://www.mdpi.com/1424-8220/21/6/1929
work_keys_str_mv AT alexanderrodriguez electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT franciscoburgosflorez electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT josedposada electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT elianacervera electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT valtencirzucolotto electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT homerosanjuan electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT marcosanjuan electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
AT pedrojvillalba electrochemicalimmunosensorforthequantificationofs100batclinicallyrelevantlevelsusingacysteaminemodifiedsurface
_version_ 1724226436295819264